Company profile: Biocare Medical
1.1 - Company Overview
Company description
- Provider of automated immunohistochemistry (IHC) instrumentation and the full range of reagents for IHC lab testing; market leader in simultaneous multiplex IHC tests. Offers ONCORE Pro for IHC/FISH, intelliPATH+ automated staining, ARC antigen retrieval, Q Series antibodies for Leica Bond instruments, sequence-specific FISH probes, and Empire Genomics clinical and custom molecular probes.
Products and services
- ONCORE Pro: A laboratory-grade automated instrument for IHC and FISH applications, capable of running both application types in a single lab to enable combined assay execution
- IntelliPATH+: An industrial-grade advanced staining instrument automating IHC staining processes, supporting high-throughput diagnostics and research within laboratory settings
- FISH Probes: Automation-ready sequence-specific probes engineered for automated FISH applications, delivering precise results for cancer and disease state identification
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biocare Medical
Aran Biomedical
HQ: Ireland
Website
- Description: Provider of design, development, and manufacturing of biomaterial-based medical implants, specializing in medical textiles, implant coatings, biomaterial frame encapsulation, and resorbable implantable solutions. Services span concept development, prototyping, and volume manufacturing, with knitting, braiding, weaving for implantable polymers, plus dip and spray coating using resorbable and non-resorbable materials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aran Biomedical company profile →
Applied StemCell
HQ: United States
Website
- Description: Provider of animal and cell line models as tools for drug discovery and diagnostics, leveraging proprietary TARGATT gene modification technology to create site-specific knock-in mouse, rat, and human cell line models quickly and efficiently for the pharmaceutical and academic community.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied StemCell company profile →
Primerdesign
HQ: United Kingdom
Website
- Description: Provider of real-time PCR solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Primerdesign company profile →
Abraxis BioScience
HQ: United States
Website
- Description: Provider of next-generation therapeutics and core technologies for the treatment of cancer and other critical illnesses; engages in the discovery, development, and delivery of therapies, including Abraxane, a nanoparticle chemotherapeutic compound.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abraxis BioScience company profile →
Cytek Biosciences
HQ: United States
Website
- Description: Provider of flow cytometry products and services, including Aurora full spectrum profiling flow cytometer (detects up to 40 colors), Aurora CS cell sorter for high-resolution sorting and analysis, Northern Lights cytometer for basic assays to multicolor immunophenotyping, Orion automated reagent cocktail preparation system, Enhanced Small Particle (ESP) detection option for extracellular vesicles, and Amnis AI v3.0 imaging analysis software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytek Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biocare Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biocare Medical
2.2 - Growth funds investing in similar companies to Biocare Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biocare Medical
4.2 - Public trading comparable groups for Biocare Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →